TNF and inflammatory bowel disease: For example, there is a European evidence-based consensus to continue treatment with anti-TNFα for inflammatory bowel disease (IBD) throughout pregnancy, given the risks of IBD also for the fetus, even with an FDA Category B/C designation for this drug [44].